Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone

10BagR

May 30, 2017 07:54AM

Re: Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone

DNDStocks

May 30, 2017 02:37PM

Re: Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone

BearDownAZ

May 30, 2017 02:52PM

DNDStocks

Rank: Treasurer [?]

Points: 568 [?]

Votes: 13 Score: 2.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone

in response to

Re: Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone

BearDownAZ

posted on May 30, 2017 03:34PM

Thanks Bear, I had missed that. I didnt know we were perusing this trial.

Thanks

DND

2 Recommendations

Reply New Message

Back To Forum List View

Please to post a reply